CD5 and mantle cell lymphoma: As proof that the CD19−CD133+ cells were derived from the MCL cell population and not from contaminating normal HSC, we evaluated UCB CD5+ B-cells, bulk MCL cells, and the CD19−CD133+ cells for the t(11;14)(q13;q32) translocation that is characteristic of MCL.